The latest Investing Matters Podcast episode with multi-award-winning fund manager and international bestselling author Lee Freeman-Shor has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 253.00
Bid: 251.00
Ask: 254.00
Change: 5.00 (2.02%)
Spread: 3.00 (1.195%)
Open: 248.00
High: 253.00
Low: 246.00
Prev. Close: 248.00
GFRD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Settlement of AWPR

23 Dec 2019 11:00

RNS Number : 8332X
Galliford Try PLC
23 December 2019
 

 

 

 

 

 

 

Galliford Try plc

Settlement agreed on Aberdeen Western Peripheral Route

 

Galliford Try plc ("Galliford Try"), the housebuilding, regeneration and construction group announces that, following a lengthy period of negotiation, the Aberdeen Western Peripheral Route ("AWPR") joint venture has substantially agreed settlement terms with the client in respect of the final account of this major infrastructure project. As a result of the settlement Galliford Try expects to receive a cash payment of around £32m and incur a write-off of £52m.

 

The settlement brings to a conclusion a complex and challenging project, averting a lengthy and costly litigation process. The settlement also removes a significant distraction and uncertainty, allowing the Construction business to focus on its core business, current and new projects which are expected to deliver improving margins, operating on multiple secured frameworks and in our chosen sectors. 

 

Taken together with an adverse adjudication award on an unrelated historical contract in the period, the Group will report an exceptional write-off of circa £61m at 31 December 2019.

 

The person responsible for making this announcement on behalf of Galliford Try is Kevin Corbett, General Counsel & Company Secretary. This announcement contains inside information for the purposes of article 7 of EU Regulation 596/2014.

 

For further enquiries please contact:

 

Galliford Try

Graham Prothero, Chief Executive 01895 855001

Andrew Duxbury, Finance Director

 

Tulchan Communications

James Macey White 020 7353 4200

Martin Pengelley

Elizabeth Snow

 

 

Galliford Try plc is a leading UK housebuilding, regeneration and construction group. It is listed on the London Stock Exchange and a member of the FTSE 250. Housebuilding - through our Linden Homes business - develops private and affordable homes in prime locations. Galliford Try Partnerships - our regeneration business - delivers mixed-tenure solutions working with housing association, local authority and private sector partners. Operating as Galliford Try and Morrison Construction, our Construction business carries out building and infrastructure with clients in the public, private and regulated sectors. At the end of the last financial year to 30 June 2019, the Group generated revenue of £2.8bn. On 7 November 2019 the Group announced it had entered into an agreement with Bovis Homes Group PLC regarding a combination of Bovis Homes and the Group's housebuilding businesses, Linden Homes and Partnerships & Regeneration. The transaction is expected to complete on 3 January 2020.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBXLFLKLFEFBK
Date   Source Headline
28th Mar 201811:00 amRNSDirector/PDMR Shareholding
27th Mar 20181:11 pmRNSPublication of Prospectus
27th Mar 20187:00 amRNSAnnouncement re: Rights Issue
20th Mar 201810:00 amRNSHolding(s) in Company
1st Mar 201812:00 pmRNSTotal Voting Rights
1st Mar 201810:00 amRNSHolding(s) in Company
14th Feb 20187:00 amRNSFully Underwritten £150 million Capital Raising
14th Feb 20187:00 amRNSHalf-year Report
5th Feb 201810:00 amRNSHolding(s) in Company
1st Feb 201812:00 pmRNSTotal Voting Rights
15th Jan 201811:04 amRNSJoint Venture with Carillion plc
2nd Jan 201812:00 pmRNSTotal Voting Rights
5th Dec 20173:00 pmRNSBlock Listing Application
4th Dec 201710:00 amRNSHolding(s) in Company
1st Dec 201712:00 pmRNSTotal Voting Rights
27th Nov 201712:00 pmRNSBlock listing Interim Review
17th Nov 201710:00 amRNSHolding(s) in Company
16th Nov 20177:00 amRNSContract
15th Nov 201710:00 amRNSHolding(s) in Company
14th Nov 201710:00 amRNSDirector/PDMR Shareholding
13th Nov 20172:00 pmRNSHolding(s) in Company
10th Nov 20173:00 pmRNSHolding(s) in Company
10th Nov 201712:30 pmRNSResult of AGM
10th Nov 20177:00 amRNSAGM Statement
9th Nov 20173:00 pmRNSDirector/PDMR Shareholding
1st Nov 201712:00 pmRNSTotal Voting Rights
25th Oct 201710:00 amRNSHolding(s) in Company
24th Oct 201710:00 amRNSHolding(s) in Company
6th Oct 201712:00 pmRNSDirector/PDMR Shareholding
5th Oct 201710:15 amRNSAnnual Financial Report
3rd Oct 201712:00 pmRNSDirector/PDMR Shareholding
3rd Oct 201712:00 pmRNSDirector/PDMR Shareholding
3rd Oct 201712:00 pmRNSDirector/PDMR Shareholding
2nd Oct 201712:00 pmRNSTotal Voting Rights
25th Sep 201712:00 pmRNSDirector/PDMR Shareholding
25th Sep 201712:00 pmRNSDirector/PDMR Shareholding
21st Sep 201712:00 pmRNSDirector/PDMR Shareholding
13th Sep 20177:00 amRNSFinal Results
1st Sep 201712:00 pmRNSDirectorate Change
17th Aug 20174:30 pmRNSHolding(s) in Company
15th Aug 20174:00 pmRNSHolding(s) in Company
7th Aug 20172:00 pmRNSTotal Voting Rights
3rd Aug 20174:00 pmRNSHolding(s) in Company
27th Jul 20174:30 pmRNSHolding(s) in Company
11th Jul 20177:00 amRNSTrading Statement
3rd Jul 20172:59 pmRNSTotal Voting Rights
12th Jun 201710:00 amRNSHolding(s) in Company
7th Jun 20177:00 amRNSDirectorate Change
1st Jun 20172:00 pmRNSTotal Voting Rights
23rd May 20172:00 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.